Beijing Strong Biotechnologies (SZSE:300406) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Beijing Strong Biotechnologies Change In Receivables?

Beijing Strong Biotechnologies's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Beijing Strong Biotechnologies's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Beijing Strong Biotechnologies's change in receivables for the fiscal year that ended in Dec. 2023 was ¥-69 Mil. It means Beijing Strong Biotechnologies's Accounts Receivable increased by ¥69 Mil from Dec. 2022 to Dec. 2023 .

Beijing Strong Biotechnologies's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥1,131 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Beijing Strong Biotechnologies's Days Sales Outstanding for the three months ended in Mar. 2024 was 261.95.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Beijing Strong Biotechnologies's liquidation value for the three months ended in Mar. 2024 was ¥564 Mil.

Beijing Strong Biotechnologies Change In Receivables Historical Data

The historical data trend for Beijing Strong Biotechnologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Strong Biotechnologies Change In Receivables Chart

Beijing Strong Biotechnologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-135.34

-34.01

-184.23

-84.94

-69.02

Beijing Strong Biotechnologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Beijing Strong Biotechnologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Beijing Strong Biotechnologies (SZSE:300406) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Beijing Strong Biotechnologies's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1130.764	/	393.895	*	91
=	261.95

2. In Ben Graham's calculation of liquidation value, Beijing Strong Biotechnologies's accounts receivable are only considered to be worth 75% of book value:

Beijing Strong Biotechnologies's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1033.782	-	1435.804	+	0.75 * 1130.764	+	0.5 * 236.851
=	564

Beijing Strong Biotechnologies Change In Receivables Related Terms

Thank you for viewing the detailed overview of Beijing Strong Biotechnologies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Strong Biotechnologies (SZSE:300406) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Beijing Strong Biotechnologies Inc (SZSE:300406) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 15 Hua Yuan Dong Lu, 5th Floor, Kuang Yi Building, Haidian District, Beijing, CHN, 100191

Website

http://www.bsbe.com.cn

Beijing Strong Biotechnologies Inc is a China-based provider of in-vitro (IVD) diagnostics products and service. The company is engaged in the research, development, production, and sale of IVD products. It also provides diversified clinical diagnosis solutions to customers. Its products include clinical biochemistry testing, coagulation testing, blood typing, serology and automated blood grouping analyzer. The firm has established a clinical biochemistry platform of the enzymatic method (including enzymatic cycling method), immunoturbidimetric method, and latex immunoturbidimetric method.

Executives

Shuang He	Executives
Luo Ai Ping	Director
	Directors, executives
Liu Wei	Executives
Zhou Ming	Executives
Zhuang Xian Min	Directors, executives
Zhang Yi	Executives
Liu Xi	Directors, executives
Sun Xiao Lin	Director
Yu Jian Ping	Executives

Beijing Strong Biotechnologies (SZSE:300406) Headlines

No Headlines